PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Nov 2004 (Vol: 2004, Issue: 53)

Next Issue >>

Section: Business Commentaries
Alliances are Forever? Published: 1 Nov-2004
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
TopoTarget AS Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Xerion Pharmaceuticals AG Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Raptiva (efalizumab) Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
ISTA and Allergan in New Vitrase® Collaboration Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Section: General
Aradigm’s Confidence Boosted by Novo Nordisk Published: 4 Nov-2004
By: Business Review Editor
Abstract
Section: Licensing
Forest Labs Licenses Respiratory Drug from Glenmark Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Nastech and Merck to Co-Develop Nasal Spray for Obesity Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Exelixis to Merge with X-Ceptor Therapeutics Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Novartis Validates Xenon and its Obesity Programme with US$157 M Deal Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:
Gilead and Genelabs Form Hepatitis C Alliance Published: 4 Nov-2004
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in

Bookmark PharmaDeals through one of these social networks.